Additionally, transfection with constitutively-active STAT5 has been associated with superior anti-tumor activity in mouse models of malignancy, and CAR-T cells engineered toward increased STAT5 activity demonstrate improved proliferation and polyfunctionality while preventing terminal differentiation (71, 72, 74, 75, 86). This evidence concerns the gene STAT5B and neoplasm.